Authors
Latest:
CDC Calls on Pharmacists to Aid HIV EpidemicPharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.
Latest:
Opinion: PharmD Quality vs Quantity"Our focus is making sure students have the best information to make career and program decisions at the time of application," writes Peter Vlasses.
Latest:
Opinion: Your Approach to Hiring is All Wrong"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan
Latest:
Implementing Enhanced Community Pharmacy ServicesNew study examines effective implementation of team-based care in community pharmacies.
Latest:
Pharmacists at the FDA: Drug Information SpecialistsAgents of regulatory guidance, drug problem reports, and whistleblowers.
Latest:
Pharmacists at the FDA: Drug Information SpecialistsAgents of regulatory guidance, drug problem reports, and whistleblowers.
Latest:
New Institute Aims to Get the Medications RightComprehensive medication management may lower costs and improve lives.
Latest:
Discount Cards: A Rebuttal"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch.
Latest:
Opinion: Clinician Burnout is Everyone's ProblemHow can we protect the health of the millions of people who protect our own?
Latest:
Physician Dispensing and the Opioid CrisisPharmacists must continue to minimize the convenience gap between physician and pharmacy.
Latest:
Physician Dispensing and the Opioid CrisisPharmacists must continue to minimize the convenience gap between physician and pharmacy.
Latest:
Birth Control Services Help Attract and Keep PatientsPrescribing more hormonal methods is an important expansion of existing services and offerings.
Latest:
New Drug Review: Vraylar for Bipolar I DisorderCariprazine demonstrated greater improvement on the MADRS.
Latest:
Opinion: Patient-Centered Care and the Heart of Independents"Community pharmacies have reasons to be optimistic..." writes Jhaveri.
Latest:
New Drug Review: Pretomanid for Highly Drug Resistant TuberculosisIndicated as part of a three-drug oral combination.
Latest:
Independent Pharmacy: A Day in the LifeSimon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.
Latest:
Opinion: The Truth About ARCOS and the Opioid EpidemicThe DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
Latest:
New Drug Review: Tafamidis Meglumine for CardiomyopathyApproved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Latest:
New Drug Review: Tafamidis Meglumine for CardiomyopathyApproved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
Latest:
Toxicity Management Crucial When Combining Novel AgentsOff-label drug combinations are increasingly being used in cancer treatments, but there is the potential for overlapping or additive toxicities, explained a speaker at the 2023 HOPA Annual Conference.
Latest:
Pharmacists Can Help Patients as Signs of Normalcy ReturnAlthough COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.
Latest:
Build a Successful Hospital Pharmacy Analytics ProgramLeverage internal partnerships and demonstrate the value of data
Latest:
Can Pharmacists be Blamed as Co-Conspirators in the Opioid Crisis?What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.
Latest:
New Measles and Rubella Vaccine Found to be Safe and EffectiveMebella is another weapon in the global fight to eradicate these diseases.
Latest:
All Ages Need Education on SunscreenData from one study showed younger women more likely to use sunscreen than older adults.
Latest:
Relying on Your Distributor Through Natural DisastersThe critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain
Latest:
The Impact of Patents and Exclusivities on FDA’s Approval of Generic DrugsWhat are some of the factors affecting whether a brand-name drug has generic competition?
Latest:
Lefamulin (Xenleta) for Community Acquired Bacterial PneumoniaLefamulin was approved by the FDA in August 2019 for the treatment of CABP.
